To examine the mortality related to procedures performed to treat benign prostate hyperplasia (BPH) in Finland and identify potential risk factors for increased mortality, emphasizing the significance of these factors in clinical decision-making.
Key Findings:
Out of 39,320 patients, 431 died within 90 days post-surgery, resulting in a mortality rate of 1.10%, highlighting the need for careful patient selection.
TURP had a higher mortality rate (1.16%) compared to laser vaporization (0.59%), suggesting a need for further investigation into procedural risks.
Majority of patients (70%) had a Charlson comorbidity index score of 0, indicating a generally low comorbidity burden in the study population.
Interpretation:
The study indicates that surgical procedures for BPH carry a notable risk of postoperative mortality, particularly with TURP, highlighting the need for careful consideration of patient comorbidities and age in surgical decision-making, which is crucial for improving patient outcomes.
Limitations:
Exclusion of emergency operations and patients from institutional care may limit generalizability, potentially skewing the mortality rates.
Retrospective design may introduce biases in data collection and interpretation, necessitating cautious interpretation of the findings.
Conclusion:
The findings underscore the importance of evaluating surgical risks in elderly and comorbid patients undergoing BPH procedures, with implications for clinical practice in urology and a call for further research to refine surgical guidelines.
